Skip to content
GLP-1 Decoder

New Hampshire Medicaid GLP-1 Coverage: Wegovy, Zepbound

Not for weight loss. New Hampshire Medicaid covers GLP-1s only for type 2 diabetes and other approved uses. New Hampshire Medicaid stopped covering GLP-1s for weight loss in January 2026. They stay covered for diabetes and other approved uses.

For weight loss
Ended January 2026
For type 2 diabetes
Covered
Weight loss, KFF survey January 2026
Not covered

Does New Hampshire Medicaid cover GLP-1s?

Sources: KFF 1 2.

Drug by drug: Wegovy, Zepbound, Ozempic, and Mounjaro

GLP-1 drugs in New Hampshire Medicaid
MedicineMain useIn New Hampshire MedicaidEvery state
WegovyWeight lossEnded January 2026Wegovy and Medicaid
ZepboundWeight lossEnded January 2026Zepbound and Medicaid
FoundayoWeight lossEnded January 2026Not listed
SaxendaWeight lossEnded January 2026Saxenda and Medicaid
OzempicType 2 diabetesCovered for type 2 diabetesOzempic and Medicaid
MounjaroType 2 diabetesCovered for type 2 diabetesMounjaro and Medicaid
RybelsusType 2 diabetesCovered for type 2 diabetesRybelsus and Medicaid
TrulicityType 2 diabetesCovered for type 2 diabetesTrulicity and Medicaid
VictozaType 2 diabetesCovered for type 2 diabetesVictoza and Medicaid

Sources: KFF.

Rules for getting prior authorization

Source: KFF.

How to check your plan

  1. Look up the drug on the state's list: New Hampshire Medicaid drug list.
  2. When a managed care plan runs Medicaid, call the member number on your card and ask whether prior authorization is required for the drug.
  3. Find out from your prescriber which GLP-1 is the preferred one. Preferred drugs are approved faster.
  4. Save the approval or denial notice. It shows the rule that applies in your case.

Which brand pages apply in New Hampshire?

If New Hampshire Medicaid says no

If coverage says no
MedicineLowest self-payOffer from the manufacturer if your plan does not cover the drug
Wegovy$149 a monthNot listed
Zepbound$299 a month$299 a month
Foundayo$149 a monthNot listed

Sources: foundayo.lilly.com, TrumpRx, NovoCare, CMS.